Jermasek Douglas 4
4 · Unicycive Therapeutics, Inc. · Filed Apr 17, 2024
Insider Transaction Report
Form 4
Jermasek Douglas
EVP of Corporate Strategy
Transactions
- Award
Stock Options
2024-04-15+463,250→ 1,973,250 totalExercise: $1.14Exp: 2034-04-15→ Common Stock (463,250 underlying)
Footnotes (1)
- [F1]115,813 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.